|
US5744500A
(en)
*
|
1990-01-03 |
1998-04-28 |
Teva Pharmaceutical Industries, Ltd. |
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
|
|
IL118836A
(en)
|
1996-07-11 |
2001-01-11 |
Teva Pharma |
Pharmaceutical compositions comprising s-(-)-n-propargyl-1-aminoindan
|
|
AU2002244247B2
(en)
|
2001-03-01 |
2007-12-13 |
Harbor Biosciences, Inc. |
Use of certain steroids for treatment of blood cell deficiencies
|
|
CA2496867A1
(en)
|
2002-08-28 |
2004-03-11 |
Hollis-Eden Pharmaceuticals, Inc. |
Therapeutic treatment methods
|
|
AU2003282337B2
(en)
*
|
2002-11-07 |
2009-07-16 |
Technion Research And Development Foundation Ltd. |
Neuroprotective iron chelators and pharmaceutical compositions comprising them
|
|
US7396860B2
(en)
|
2002-11-15 |
2008-07-08 |
Teva Pharmaceutical Industries, Ltd. |
Use of rasagiline with or without riluzole to treat amyotrophic lateral sclerosis
|
|
CA2547053C
(en)
|
2003-11-25 |
2014-05-27 |
Technion Research & Development Foundation Ltd. |
Compositions and methods for treatment of cardiovascular disorders and diseases
|
|
US8097608B2
(en)
*
|
2003-11-25 |
2012-01-17 |
Technion Research And Development Foundation Ltd. |
Methods for treatment of cardiovascular disorders and diseases
|
|
JP2005232148A
(ja)
*
|
2004-02-03 |
2005-09-02 |
Technion Research & Development Foundation Ltd |
神経保護剤としてプロパルギルアミンの使用
|
|
WO2006014973A2
(en)
*
|
2004-07-26 |
2006-02-09 |
Teva Pharmaceutical Industries, Ltd. |
Pharmaceutical dosage forms including rasagiline
|
|
US20060025446A1
(en)
*
|
2004-07-27 |
2006-02-02 |
Jeffrey Sterling |
Propargyl nitroxides and indanyl nitroxides and their use for the treatment of neurologic diseases and disorders
|
|
AU2005330504B2
(en)
|
2004-09-29 |
2010-10-28 |
Harbor Biosciences, Inc. |
Steroid analogs and characterization and treatment methods
|
|
US20080261894A1
(en)
*
|
2005-02-17 |
2008-10-23 |
Rivka Kreitman |
Combination Therapy with Glatiramer Acetate and Rasagiline for the Treatment of Multiple Sclerosis
|
|
RU2404746C2
(ru)
|
2005-02-23 |
2010-11-27 |
Тева Фармасьютикал Индастриз, Лтд. |
Композиции разагилина с улучшенной однородностью содержимого
|
|
US8263655B2
(en)
*
|
2005-10-06 |
2012-09-11 |
Technion Research And Development Foundation Ltd |
Methods for treatment of renal failure
|
|
CN101622225B
(zh)
*
|
2005-11-17 |
2015-04-15 |
泰华制药工业有限公司 |
炔丙基氨基茚分离方法
|
|
US7572834B1
(en)
|
2005-12-06 |
2009-08-11 |
Teva Pharmaceutical Industries, Ltd. |
Rasagiline formulations and processes for their preparation
|
|
JP2009518433A
(ja)
*
|
2005-12-09 |
2009-05-07 |
イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブライ ユニバーシティー オブ エルサレム |
神経保護用の低用量ラドスチギルの使用
|
|
AU2007217349B9
(en)
|
2006-02-21 |
2013-06-27 |
Teva Pharmaceutical Industries, Ltd. |
Use of rasagiline for the treatment of Multiple System Atrophy
|
|
TW200744576A
(en)
|
2006-02-24 |
2007-12-16 |
Teva Pharma |
Propargylated aminoindans, processes for preparation, and uses thereof
|
|
EP2007369A4
(en)
|
2006-04-03 |
2009-07-01 |
Teva Pharma |
USE OF RASAGILINE FOR THE TREATMENT OF LEG SYNDROME WITHOUT REST
|
|
EP1892233A1
(de)
*
|
2006-08-18 |
2008-02-27 |
Ratiopharm GmbH |
Neue Salze des Wirkstoffs Rasagilin
|
|
CA2672452C
(en)
*
|
2006-12-14 |
2012-07-03 |
Teva Pharmaceutical Industries Ltd. |
Tannate salt of rasagiline
|
|
US7750051B2
(en)
*
|
2006-12-14 |
2010-07-06 |
Teva Pharmaceutical Industries, Ltd. |
Crystalline solid rasagiline base
|
|
EP1987816A1
(de)
*
|
2007-04-30 |
2008-11-05 |
Ratiopharm GmbH |
Adsorbate eines Rasagilinsalzes mit einem wasserlöslichen Hilfsstoff
|
|
EP2194780A4
(en)
*
|
2007-09-05 |
2010-10-27 |
Teva Pharma |
METHOD FOR TREATING GLAUCOMA BY RASAGILINE
|
|
US8188149B2
(en)
*
|
2007-09-17 |
2012-05-29 |
Teva Pharmaceutical Industries, Ltd. |
Use of R(+)-N-propargy1-1-aminoindan to treat or prevent hearing loss
|
|
MX2010007601A
(es)
*
|
2008-01-11 |
2010-08-03 |
Teva Pharma |
Formulaciones de rasagilina, su preparacion y uso.
|
|
WO2009122351A2
(en)
*
|
2008-04-01 |
2009-10-08 |
Kangwon National University |
Anti-parkinsonian compounds mppe
|
|
US20100008983A1
(en)
*
|
2008-06-10 |
2010-01-14 |
Muhammad Safadi |
Rasagiline soft gelatin capsules
|
|
BRPI0909894A2
(pt)
*
|
2008-06-13 |
2015-07-28 |
Teva Pharma |
"método de redução da velocidade de progressão de mal de parkinson em um paciente com mal de parkinson em estágio inicial, método de redução da velocidade de progressão de mal de parkinson, método de atraso da necessidade de terapia antiparkinsoniana sintomática em um paciente de mal de parkinson em estágio inicial, método de redução do risco de um paciente com mal de parkinson que necessita de terapia antiparkinsoniana, método de redução do declínio funcional de um paciente com mal de parkinson em estágio inicial, método de redução do declínio funcional em um paciente com mal de parkinson, método de tratamento de um paciente que exibe sinais iniciais de mal de parkinson, método de redução da fadiga em um paciente com mal de parkinson em estágio inicial, método de redução da velocidade de progressão clínica e tratamento de sintomas de mal de parkinson em um paciente com mal de parkinson, rasagilina ou um sal farmaceuticamente aceitável de rasagilina, composição farmacêutica.
|
|
US7968749B2
(en)
*
|
2008-06-19 |
2011-06-28 |
Teva Pharmaceutical Industries, Ltd. |
Process for preparing and drying solid rasagiline base
|
|
US8334409B2
(en)
*
|
2008-06-19 |
2012-12-18 |
Teva Pharmaceutical Industries, Ltd. |
Process for purifying rasagiline base
|
|
US20100189791A1
(en)
*
|
2009-01-23 |
2010-07-29 |
Teva Pharmaceutical Industries, Ltd. |
Delayed release rasagiline malate formulation
|
|
DK2451771T3
(da)
|
2009-07-09 |
2014-09-08 |
Ratiopharm Gmbh |
Salte af rasagilin og farmaceutiske fremstillingsmåder heraf
|
|
JP6045347B2
(ja)
|
2010-02-03 |
2016-12-14 |
ファーマ ツー ビー リミテッド |
ラサギリンの持続放出性製剤およびその使用
|
|
EP2603212A4
(en)
|
2010-07-27 |
2014-01-08 |
Teva Pharma |
USE OF RASAGILINE FOR THE TREATMENT OF SMOKING DISORDER
|
|
JP2013537530A
(ja)
|
2010-07-27 |
2013-10-03 |
テバ ファーマシューティカル インダストリーズ リミティド |
ラサギリンシトレートの分散物
|
|
BR112014008555A2
(pt)
|
2011-10-10 |
2017-04-18 |
Teva Pharma |
r(+)-n-formil-propargil-aminoindano
|
|
EA201490760A1
(ru)
|
2011-10-10 |
2014-09-30 |
Тева Фармасьютикал Индастриз Лтд. |
R(+)-n-метилпропаргиламиноиндан
|
|
EP2884972A4
(en)
|
2012-08-17 |
2016-05-11 |
Teva Pharma |
PARENTERAL FORMULATION OF RASAGILINE
|
|
CN104177610A
(zh)
*
|
2013-05-27 |
2014-12-03 |
韩文毅 |
一种非线性的聚合物及其制备和用途
|
|
CN104177611A
(zh)
*
|
2013-05-27 |
2014-12-03 |
韩文毅 |
一种非线性的聚合物及其制备和用途
|
|
CN111333517A
(zh)
*
|
2018-12-19 |
2020-06-26 |
上海奥博生物医药技术有限公司 |
一种制备雷沙吉兰的改进方法
|